EN

MENU

X

⤺

We share your goal of generating robust clinical evidence to demonstrate a meaningful benefit to patients

We execute faster, simpler, better and to a higher standard

We have built a large diveristy within our network and offer full range of services to our customers

We have a quality by design approach in our processes, systems and training

Clinscience is a global CRO,
delivering meaningful value in the following areas

Clinical Development

Clinical Operations

Biostatistics and Data Management

Pharmacovigilance

Clinical Quality

Temporary Resourcing Solutions

Real-World Evidence

Outsourcing of Personnel

Outsourcing of Equipment

Real world evidence

We have supported some of the largest real world evidence gathering programmes for postmarketing commitments but also for enhanced reimbursment.

We Build Trust In All Our Interactions

Our team have the experience of the nuances in the clinical development of small molecules, biological agents and advanced therapeutics. We have supported and continue to support pharmaceutical companies (big and small) and also biotechnology organisation

Clinscience provide
a full-range of services to the following sectors

We provide clarity where there is ambiguity
and find opportunities when there is uncertainty

Therapeutic Area Expertise

Over the years we have supported organisations across many therapeutic areas, from pivotal global phase III oncology programmes through to very niche esoteric clinical packages of activity. Our passion for science, an unwavering commitment to improve the lives of patients and an unflagging energy to deliver on commitments has enabled us to gain broad expertise.

Oncology & Haematology

Orthopaedics & Wound Healing

Central Nervous System (CNS)

Women’s & Male Health

Immunology and Cancer Immunotherapy

Respiratory Medicine

Metabolic & Endocrinology

Rare & Orphan Disease

Gastroenterology

Infectious Diseases

Newsroom

From study protocol to Clinical Study Report in Covid-19 environment

From study protocol to Clinical Study Report in Covid-19 environment A step ahead in clinical trials even during Covid-19.

A positive decision for BIOOPA study

A positive decision for BIOOPA study At the beginning of October the Polish Competent Authority, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products gave permission for conducting the BIOOPA clinical.

What are the new possibilities to help patients with melanoma?

What are the new possibilities to help patients with melanoma? Melanoma is one of the most dangerous oncological diseases and although it accounts for only 4% of all dermatologic cancers, it is responsible for 80% of deaths from skin cancer. Study results have shown that only 14% of patients with metastatic melanoma survive for five years or more.

Request for information

Request for proposal

How can we help you?